Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Feature Articles
7/12/2024
Prominence of Asia in Global Pharma Clinical Trials Rising Substantial...
7/11/2024
Political Change Around China Means Change for Pharma (The Medicine Ma...
7/11/2024
Biopharma Partnership Interest with China Remains High: LEK Survey
7/10/2024
House Speaker Mike Johnson Pledges Vote for BIOSECURE as China-targeti...
7/9/2024
China's Pharmaceutical Industry Bets Big on Small Nucleic Acid Drugs i...
7/9/2024
China's Supreme People's Court Clarifies Priority Examination Standard...
7/2/2024
What is the Current Landscape of Obesity Drug Development in China? (L...
6/27/2024
Industry Braces for Biosecure Act Impact (C&EN)
6/26/2024
On Efficiency of China's Drug-Related Patent Term Compensation System ...
6/25/2024
Leveraging Injunctive Relief in Pharmaceutical Patent Disputes in Chin...
6/20/2024
Cheaper Versions of Blockbuster Obesity Drugs Are Being Created in Ind...
6/19/2024
Big Changes to China's BMI System Expected at 3rd Plenum (Pekingnology...
6/18/2024
China Biopharma Tracker – May 2024 (PharmaDJ)
6/14/2024
In Depth: How China's Pricing Regime Penalizes Innovative Drugmakers (...
6/4/2024
China Biotech Podcast: Going Global Trends, Rare Disease Drug Developm...
6/3/2024
Western Companies Drive Chinese Biotech Licensing Deal Blitz (FT)
5/31/2024
Building Resilient Supply Chains in the Face of Tightening Chinese Ant...
5/31/2024
Manufacturing Inspections Down in China amid Arrest Fears and No Acces...
5/30/2024
U.S. Rethinks Timing of Biotech Crackdown, Easing Pressure on WuXi Fam...
5/29/2024
Caixin Explains: How China Is Overhauling Regulations on Genetic Resou...
5/23/2024
Hong Kong Emerges As Global Health Innovation Hub Under China New Plan...
5/21/2024
Chinese Biotechs Remain Optimistic About Cross-border Cooperations Des...
5/21/2024
With $5B in China Sales, AstraZeneca Doubles Down on Chinese Biopharma...
5/21/2024
China's Investigator Trials Accelerate Competitive CAR T Development (...
5/20/2024
China Set to Ease Controls on Genetic Resources to Plug Biotech Innova...
5/20/2024
AZ to Build US$1.5B Cancer Drug Plant In Singapore, Reduce Industry's ...
5/17/2024
Pharma Facing Growing Risks From Geopolitics, Industry Leaders Warn (S...
5/16/2024
A Snapshot of Key Events in China This Week (AmCham China Newsletter /...
5/15/2024
China Biopharma Tracker – April 2024 (PharmaDJ)
5/15/2024
Chinese Biotech Crackdown Would Reset U.S. Drug Development (Axios)
Page:
6
/
7
Total number of articles:
191
:
[First]
[<<]
[3]
[4]
[5]
[6]
[7]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit